Press & News
We are on a journey to addiction free living and every step counts. Stay up to date with the latest news and info on our growth.
Universal Ibogaine Retains Shayne Nyquvest as Capital Markets Advisor
CALGARY, AB , April 29, 2022 /CNW/ - Universal Ibogaine Inc. (TSXV: IBO) (OTCQB: IBOGF) (FSE: JC4) (" UI " [...]
Universal Ibogaine Advises of Departure of Marilyn Mauritz from Board of Directors
Calgary, AB – April 21, 2022 – Universal Ibogaine Inc. (TSXV:IBO) (“UI” or the “Company”) [...]
Universal Ibogaine Provides Update on Kelburn Recovery Center Operations
Calgary, AB – April 7, 2022 – Universal Ibogaine Inc. (TSXV:IBO) (“UI” or the “Company”) [...]
Universal Ibogaine Announces Frankfurt Stock Exchange Listing
Calgary, AB – April 5, 2022 – Universal Ibogaine Inc. (TSXV:IBO and OTCQB: IBOGF and [...]
Universal Ibogaine to Participate in the 2022 Virtual Growth Conference
Presented by Maxim Group LLC and hosted by M-Vest on March 28th – 30th from [...]
UNIVERSAL IBOGAINE EXPANDS RESEARCH TEAM WITH JULIE DUMOUCHEL, DIRECTOR OF CLINICAL TRIALS
Calgary, Alberta – March 23, 2022 – Universal Ibogaine Inc. (TSXV:IBO and OTCQB: IBOGF) (“UI” [...]
Universal Ibogaine to Present at OTC Virtual Investor Event
Universal Ibogaine Inc. to Webcast Live at OTC Markets VirtualInvestorConferences.com March 10th Company invites individual [...]
UNIVERSAL IBOGAINE ANNOUNCES APPROVAL OF TRADING ON OTCQB VENTURE MARKET
Calgary, AB – February 28, 2022 – Universal Ibogaine Inc. (TSXV:IBO and OTCQB: IBOGF) (“UI” [...]
UNIVERSAL IBOGAINE SIGNS MEMORANDUM OF UNDERSTANDING WITH OSOYOOS INDIAN BAND
Calgary, AB – February 10, 2022 – Universal Ibogaine Inc. (TSXV:IBO) (“UI” or the “Company”) [...]
UNIVERSAL IBOGAINE COMMENCES DEVELOPMENT PLAN AT KELBURN IN PREPARATION FOR IBOGAINE TREATMENTS AND PROVIDES UPDATE ON DRUG SUPPLY
CALGARY, AB, Feb. 2, 2022 /CNW/ - Universal Ibogaine Inc. (TSXV: IBO) ("UI" or the "Company") a life [...]
UNIVERSAL IBOGAINE ENTERS DRUG SUPPLY AGREEMENT
Calgary, AB – January 26, 2022 – Universal Ibogaine Inc. (TSXV:IBO) (“UI” or the “Company”) [...]
Universal Ibogaine Announces World-class Clinical Trial Partners in Advance of Clinical Trial Application For Ibogaine in Opioid Use Disorder
Calgary, AB – January 14, 2022 – Universal Ibogaine Inc. (TSXV:IBO) (“UI” or the “Company”) [...]
Universal Ibogaine Announces Change in Leadership
Calgary, AB - TheNewswire - January 10, 2022 - Universal Ibogaine Inc. (TSXV:IBO) (“UI” or the “Company”) announces [...]
Universal Ibogaine Announces Expansion of Executive Team and Grant of Stock Options
Calgary, AB - TheNewswire – December 2, 2021 – Universal Ibogaine Inc. (TSXV:IBO) (“ UI ” or the “ Company ”), [...]
UNIVERSAL IBOGAINE ANNOUNCES CHIEF CLINICS OFFICER DR IAN RABB
Universal Ibogaine and PSQ are pleased to announce the completion of the Qualifying Transaction, closing the $6 million subscription receipt financing.
UNIVERSAL IBOGAINE ANNOUNCES ENGAGEMENT OF MEDIA AND INVESTOR RELATIONS ADVISORS
Universal Ibogaine and PSQ are pleased to announce the completion of the Qualifying Transaction, closing the $6 million subscription receipt financing.
UNIVERSAL IBOGAINE ANNOUNCES ENGAGEMENT OF INVESTOR RELATIONS ADVISOR
Universal Ibogaine and PSQ are pleased to announce the completion of the Qualifying Transaction, closing the $6 million subscription receipt financing.
UNIVERSAL IBOGAINE ANNOUNCES ENHANCEMENTS TO BOARD OF DIRECTORS
Universal Ibogaine and PSQ are pleased to announce the completion of the Qualifying Transaction, closing the $6 million subscription receipt financing.
UNIVERSAL IBOGAINE COMMENCES TRADING ON THE TSX-V
Universal Ibogaine and PSQ are pleased to announce the completion of the Qualifying Transaction, closing the $6 million subscription receipt financing.
Universal Ibogaine Announces Extension of Convertible Notes Payable and Engagement of Market Maker Firms
Universal Ibogaine and PSQ are pleased to announce the completion of the Qualifying Transaction, closing the $6 million subscription receipt financing.
UNIVERSAL IBOGAINE INC. ANNOUNCES TSX-V FINAL APPROVAL OF QT, RESUMPTION OF TRADING DATE AND CLARIFICATION OF CERTAIN FILING STATEMENT DISCLOSURES
Universal Ibogaine and PSQ are pleased to announce the completion of the Qualifying Transaction, closing the $6 million subscription receipt financing.
P SQUARED RENEWABLES INC. ANNOUNCES THE COMPLETION OF QUALIFYING TRANSACTION AND THE PRIOR CLOSING OF $6 MILLION SUBSCRIPTION RECEIPT FINANCING
Universal Ibogaine and PSQ are pleased to announce the completion of the Qualifying Transaction, closing the $6 million subscription receipt financing.
P SQUARED RENEWABLES INC. AND UNIVERSAL IBOGAINE INC. ANNOUNCE FILING OF FILING STATEMENT ON SEDAR
Universal Ibogaine and PSQ are pleased to announce that PSQ has SEDAR filed...
P SQUARED RENEWABLES INC. AND UNIVERSAL IBOGAINE INC. ANNOUNCE TSX.V CONDITIONAL APPROVAL OF QUALIFYING TRANSACTION
Calgary, Alberta - P Squared Renewables Inc. (TSXV: PSQ.P) ("PSQ" or the "Company") a capital [...]
P Squared Renewables Inc. Provides Update on Con-Current Financing and QT and Announces Changes to Board Of Directors
Calgary, Alberta - P Squared Renewables Inc. (TSXV: PSQ.P) ("PSQ" or the "Company") a capital [...]
